Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02105233 : Improving Ultrasound Images in Brain Tumor Surgery With the Use of Brain Mimicking Fluid
PhasePhase 1
AgesMin: 18 Years Max: N/A
Eligibility
Inclusion Criteria:

- A glioblastoma is suspected when there is a solitary brain tumour with ring-like
contrast enhancement and oedema with no recent history (last 3 years) of primary
tumour elsewhere

- In cases where histopathology is not known from previous biopsy or resection (i.e.
diagnosis is suspected based on MRI findings and not from previous surgery) a tissue
sample for frozen section is necessary. The fluid will only be used in cases where
glioblastoma is suggested from this preliminary histopathological assessment.

Exclusion Criteria:

- Intended biopsy only (meaning: cases not suitable for resection)

- Other entities than glioblastoma is suspected

- Allergy to diary products and marine products

- Hypersensitvity to egg protein

- Hypersensitivity to soya or peanut protein

- Hypersensitvity to glycerol
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT02105233      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740